Empowering Businesses Xentria Meitheal, the Ultimate Networking Hub

Xentria landed a nearly $700 million licensing agreement with Meitheal Pharmaceuticals, a local drugmaker that spun out Xentria in 2020. Read ... Chicago, IL – September 21, 2023 – Meitheal Pharmaceuticals, Inc. (Meitheal), a fully integrated biopharmaceutical company based in Chicago ... Tom Matthews is a former employee of Meitheal Pharmaceuticals, Inc. and a current employee of Xentria, Inc. Vivek B. Ajmani, Zhun Cao, Laura L. Schott, and Manu ... Xentria and Meitheal Pharmaceuticals Announce Exclusive Licensing Agreement for XTMAB-16 in North America. 27 June 2023. Press Release: Positive topline Phase ... Under the terms of the agreement, Meitheal Pharmaceuticals gains exclusive rights to commercialize XTMAB-16 in North America and Xentria remains ... Xentria Announces Exclusive Licensing Agreement with New York University to ... Meitheal Pharmaceuticals Grows Specialty Biopharmaceuticals Portfolio ... ... Meitheal（被许可方）拟与Xentria签署许可协议，Xentria授予被许可方在许可区域开发和商业化XTMAB的独占许可，并向被许可方/被许可方代表转让与XTMAB相关的专利、技术 ... Xentria Inc a clinicalstage biotherapeutics company focused on developing therapeutics to address unmet clinical needs and Meitheal Pharmaceuticals Inc today ... Tom is the founding CEO of Meitheal since its inception in 2017. In addition, Tom is also the founding President of Xentria, Inc. ... Meitheal拟与Xentria签署《许可协议》，Xentria授予被许可方在许可 ... Xentria,Inc（以下简称“Xentria”）目前不属于上市公司，公司未查询到其 ...